Please assess the completion status of the following clinical trial:

Trial Title: ORthopaedic Trauma Anemia With Conservative Versus Liberal Transfusion

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Trauma patients admitted to participating hospital with any Orthopaedic injury who have been determined to be stable by the Trauma Service (General Surgery) and are no longer within the resuscitation phase of initial treatment. This is defined as a normal urine output (greater than 0.5 ml/kg/hr) and a systolic blood pressure greater than 90 mmHg for greater than 6 hours without fluid bolus or transfusion during that time~* Age 18-50~* Hemoglobin less than 9 g/dL or expected drop below 9 g/dL with planned surgery~Exclusion Criteria:~* Pregnant ( urine pregnancy test will be done as standard of care)~* Prisoner~* Head injury (Glasgow Coma Scale less than 8 over 48 hours from presentation)~* Known cardiac (coronary artery disease, atrial fibrillation, stent placement, congestive heart failure), renal (acute or chronic renal insufficiency or failure, defined as having Serum Creatinine \>1.2 at time of enrollment), liver (Childs C cirrhosis) or pulmonary disease (chronic obstructive pulmonary disease, abnormal pulmonary function tests or history of poor pulmonary function from any cause including acute traumatic conditions such as ARDS)~* Unlikely to follow up in the surgeon's estimation~* Sickle Cell Anemia~* History of cancer~* Preexisting weakness, paresthesias, deformities, or other conditions which might affect functional outcome in the surgeon's opinion~* Spinal cord injury~* Patients with burns expected to require operative treatment~* COVID positive

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Liberal (Type: OTHER): Blood and blood products for transfusion. Transfusion will be done to keep Hgb \>7 g/dL.
- Conservative (Type: OTHER): Blood and blood products for transfusion. Transfusion will be done to keep Hgb \> 5.5 g/dL.

Based on this trial design, predict the completion outcome and termination type (if applicable).